Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: Results of the 1-year ESLIBASE retrospective study
Authors:
- 1 September 2014
- journal article
- Published by Elsevier in Epilepsy Research
- Vol. 108 (7) , 1243-1252
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Adherence to antiepilepsy drug therapyEpilepsy & Behavior, 2012
- Satisfaction with antiepileptic drugs in children and adolescents with newly diagnosed and chronic epilepsyEpilepsy Research, 2012
- Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsyEpilepsy Research, 2010
- Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009Epilepsia, 2010
- The evolution of antiepileptic drug development and regulationEpileptic Disorders, 2010
- Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial‐onset seizures: A randomized, double‐blind, placebo‐controlled, parallel‐group phase III studyEpilepsia, 2009
- Impact of nonadherence to antiepileptic drugs on health care utilization and costs: Findings from the RANSOM studyEpilepsia, 2009
- Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy [RETIRED]Neurology, 2004
- Anticonvulsant and Sodium Channel-Blocking Properties of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide DerivativesJournal of Medicinal Chemistry, 1999
- Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic SeizuresEpilepsia, 1981